Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia

NCT: NCT07626216 · RECRUITING

NCT IDNCT07626216
StatusRECRUITING
Start Date2026-03-04
Completion2029-05
SponsorNorthwell Health (OTHER)
First posted
Last updated

Brief Summary

By tracking resting-state fMRI scans, we aim to discover how repetitive transcranial magnetic stimulation (rTMS) changes brain connectivity in individuals with dystonia.

Frequently Asked Questions

What is Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia?

Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia is a clinical trial registered under NCT07626216. Current status: RECRUITING.

What is the status of NCT07626216?

The current status of NCT07626216 (Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia) is: RECRUITING.

When did Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia start?

Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia started on 2026-03-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.